glp-1 blue cross Independence to stop covering agonists Wegovy, Ozempic as weight loss drugs in 2025 BCBSM pulling back on GLP-1

Strong oxidizing acne treatments like benzoyl peroxide can reduce the effectiveness of vitamin C if they are used at the same time

The three GLP-1 medications approved by the FDA to treat obesity include: Liraglutide (Saxenda/Victoza) Semaglutide (Wegovy/Ozempic/Rybelsus) Tirzepatide (Zepbound/Mounjaro) GLP-1 medications can lead to an average weight loss of 10% to 20% over 12-24 months when used alongside healthy diet and exercise changes

Australas J Dermatol 53:301-302 Paurobally D et al (2011) Melanotan-associated melanoma

Furthermore, the possible promotion of cancer cell growth is increasingly being discussed with contradictory results (Table 4) that require clarification

While some patients find compounded semaglutide to be effective for weight loss, it is important to note that the FDA does not regulate compounded drugs in the same way as approved medications, which raises questions about their consistency and safety

Providers adjust based on your progress, side effects, and evolving needs